Skip to main content

Table 3 Recovery times in surviving patients according to treatment group

From: Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial

  iNO (N = 80) (median, IQR) Placebo (N = 83) (median, IQR) HR (95 % CI) p value
Time to discharge (days) 4.0 (3.0–4.0) 3.0 (3.0–4.0) 1.1 (0.83–1.6) 0.40
Time to eat (h) 17 (7–37) 10 (6–23) 1.3 (0.92–1.7) 0.15
Time to sit unsupported (h) 41 (20–75) 28 (13–60) 1.3 (0.98–1.8) 0.063
Time to localize pain (h) 5 (0–11) 2 (0–9.6) 1.2 (0.84–1.6) 0.38
Time to fever resolution (h) 6 (0–31) 6 (0–23) 1.1 (0.78–1.4) 0.73
Time to recovery of consciousness (h) 14 (6–36) 9 (4–19) 1.2 (0.90–1.7) 0.19
Time to 50 % parasite clearance (h) 12 (9–16) 12 (9–18) 0.87 (0.63–1.2) 0.37
Time to 90 % parasite clearance (h) 19 (12–37) 20 (14–37) 0.85 (0.62–1.2) 0.31
Time to parasite clearance (h) 44 (35–63) 44 (37–63) 0.97 (0.71–1.3) 0.83
  1. IQR inter-quartile range, HR hazard ratio